{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:04Z","timestamp":1787026444217,"version":"build-2736575974"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    RAR-related orphan receptor C (RORC) plays an important role in autoimmune responses and inflammation. However, its function in cancer immunity is still unclear. Its potential value in cancer immunotherapy (CIT) needs to be further studied.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Expression and clinical data for 33 cancers were obtained from UCSC-Xena. The correlation between RORC expression and clinical parameters was analyzed using the limma software package to assess the prognostic value of RORC. Timer2.0 and DriverDBv3 were used to analyze the RORC mutation and methylation profiles. RORC-associated signaling pathways were identified by GSEA. The correlations of RORC expression with tumor microenvironment factors were further assessed, including immune cell infiltration (obtained by CIBERSORT) and immunomodulators (in pancancer datasets from the Tumor-Immune System Interactions and Drug Bank [TISIDB] database). In addition, the correlations of RORC with four CIT biomarkers (tumor mutational burden, microsatellite instability, programmed death ligand-1, and mismatch repair) were explored. Furthermore, three CIT cohorts (GSE67501, GSE168204, and IMvigor210) from the Gene Expression Omnibus database and a previously published study were used to determine the association between RORC expression and CIT response.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    RORC was differentially expressed in many tumor tissues relative to normal tissues (20\/33). In a small number of cancers, RORC expression was correlated with age (7\/33), sex (4\/33), and tumor stage (9\/33). Furthermore, RORC expression showed prognostic value in many cancers, especially in kidney renal clear cell carcinoma (KIRC), brain lower grade glioma (LGG), and mesothelioma (MESO). The mutation rate of RORC in most cancer types was low, while RORC was hypermethylated or hypomethylated in multiple cancers. RORC was associated with a variety of biological processes and signal transduction pathways in various cancers. Furthermore, RORC was strongly correlated with immune cell infiltration, immunomodulators, and CIT biomarkers. However, no significant association was found between RORC and CIT response in the three CIT cohorts.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    Our findings revealed the potential immunotherapeutic value of RORC for various cancers and provides preliminary evidence for the application of RORC in CIT.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2022.969476","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T06:42:55Z","timestamp":1663224175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Shengfu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"685213","DOI":"10.3389\/fimmu.2021.685213","article-title":"Prognostic gene expression signature in patients with distinct glioma grades","volume":"12","author":"Ait Ssi","year":"2021","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1268308","DOI":"10.1080\/2162402X.2016.1268308","article-title":"Prostaglandin E(2)-mediated adenosinergic effects on CD14(+) cells: Self-amplifying immunosuppression in cancer","volume":"6","author":"Al-Taei","year":"2017","journal-title":"Oncoimmunology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1200\/PO.17.00073","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"104192","DOI":"10.1016\/j.phrs.2019.03.001","article-title":"Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists","volume":"154","author":"Bourquin","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"63261","DOI":"10.18632\/oncotarget.11211","article-title":"ROR\u03b1 and ROR\u03b3 expression inversely correlates with human melanoma progression","volume":"7","author":"Bro\u017cyna","year":"2016","journal-title":"Oncotarget"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1158\/0008-5472.CAN-18-3842","article-title":"Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1\/ITGB6\/STAT3 signaling Axis in bladder cancer","volume":"79","author":"Cao","year":"2019","journal-title":"Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3324\/haematol.2018.192062","article-title":"Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells","volume":"104","author":"Chapellier","year":"2019","journal-title":"Haematologica"},{"key":"B9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"713757","DOI":"10.3389\/fimmu.2021.713757","article-title":"TNFSF13 is a novel onco-inflammatory marker and correlates with immune infiltration in gliomas","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molimm.2021.02.011","article-title":"Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis","volume":"133","author":"Chen","year":"2021","journal-title":"Mol. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"E1760","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: Underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s40425-019-0768-9","article-title":"The role of PD-L1 expression as a predictive biomarker: An analysis of all US food and drug administration (FDA) approvals of immune checkpoint inhibitors","volume":"7","author":"Davis","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"114697","DOI":"10.1016\/j.bcp.2021.114697","article-title":"Targeting immunosuppression by TGF-\u03b21 for cancer immunotherapy","volume":"192","author":"de Streel","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.14670\/HH-18-388","article-title":"Stigmasterol inhibits the progression of lung cancer by regulating retinoic acid-related orphan receptor C","volume":"36","author":"Dong","year":"2021","journal-title":"Histol. Histopathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cellsig.2015.03.013","article-title":"Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: Role of fluoxetine","volume":"27","author":"Ghosh","year":"2015","journal-title":"Cell. Signal."},{"key":"B17","first-page":"e216987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019","volume":"8","author":"Global Burden of Disease Cancer","year":"2022","journal-title":"JAMA Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.immuni.2021.11.004.2825","article-title":"Interleukin-10 receptor signaling promotes the maintenance of a PD-1(int) TCF-1(+) CD8(+) T cell population that sustains anti-tumor immunity","volume":"54","author":"Hanna","year":"2021","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: An evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.lfs.2019.117180","article-title":"HLA-F-AS1\/miR-330-3p\/PFN1 axis promotes colorectal cancer progression","volume":"254","author":"Huang","year":"2020","journal-title":"Life Sci."},{"key":"B22","first-page":"2279","article-title":"Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer","volume":"35","author":"Ishigami","year":"2015","journal-title":"Anticancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12885-019-6054-x","article-title":"Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer","volume":"19","author":"Islam","year":"2019","journal-title":"BMC cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/bib\/bbw037","article-title":"Impacts of somatic mutations on gene expression: An association perspective","volume":"18","author":"Jia","year":"2017","journal-title":"Brief. Bioinform."},{"key":"B26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jneuroim.2013.09.006","article-title":"Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients","volume":"264","author":"Kohler","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3389\/fimmu.2018.00813","article-title":"Controlling the immune suppressor: Transcription factors and MicroRNAs regulating CD73\/nt5e","volume":"9","author":"Korda\u00df","year":"2018","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/15548627.2019.1628540","article-title":"TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status","volume":"16","author":"Liang","year":"2020","journal-title":"Autophagy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00109-020-01952-5","article-title":"TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer","volume":"98","author":"Lin","year":"2020","journal-title":"J. Mol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"21685","DOI":"10.18632\/oncotarget.3942","article-title":"Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","first-page":"D863","DOI":"10.1093\/nar\/gkz964","article-title":"DriverDBv3: A multi-omics database for cancer driver gene research","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Sci. (New York, NY)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.cell.2019.03.010.e522","article-title":"A multiscale map of the stem cell state in pancreatic adenocarcinoma","volume":"177","author":"Lytle","year":"2019","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1126\/science.1249481","article-title":"Cancer immunotherapy","volume":"342","author":"McNutt","year":"2013","journal-title":"Sci. (New York, NY)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/lrb.2020.0030","article-title":"Possible role of the RORC gene in primary and secondary lymphedema: Review of the literature and genetic study of two rare causative variants","volume":"19","author":"Michelini","year":"2021","journal-title":"Lymphat. Res. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"A49","DOI":"10.1186\/1742-4690-8-s1-a49","article-title":"Clinical significance of CADM1\/TSLC1\/IgSF4 expression in adult-T cell leukemia\/lymphoma (ATLL): Identification of various types of ATLL cells","volume":"8","author":"Nakahata","year":"2011","journal-title":"Retrovirology (Auckl)."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1210\/me.2013-1403","article-title":"PRMT2 and ROR\u03b3 expression are associated with breast cancer survival outcomes","volume":"28","author":"Oh","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"i555","DOI":"10.1093\/bioinformatics\/bty271","article-title":"GSEA-InContext: Identifying novel and common patterns in expression experiments","volume":"34","author":"Powers","year":"2018","journal-title":"Bioinforma. Oxf. Engl."},{"key":"B44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1309\/AJCP4JP8BZOMHEAW","article-title":"High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non-small cell lung cancer","volume":"141","author":"Qian","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cancers13030558","article-title":"PD-L1, TMB, MSI, and other predictors of response to immune checkpoint inhibitors in biliary tract cancer","volume":"13","author":"Rizzo","year":"2021","journal-title":"Cancers"},{"key":"B47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41571-019-0206-4","article-title":"TMB is linked with prognosis","volume":"16","author":"Romero","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"Tisidb: An integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinforma. Oxf. Engl."},{"key":"B49","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","article-title":"Helper T cell differentiation","volume":"16","author":"Saravia","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1305535","DOI":"10.1080\/2162402X.2017.1305535","article-title":"Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling","volume":"6","author":"Siska","year":"2017","journal-title":"Oncoimmunology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ijc.31922","article-title":"Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma\/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?","volume":"144","author":"Subramanian","year":"2019","journal-title":"Int. J. Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"B53","doi-asserted-by":"publisher","first-page":"100617","DOI":"10.1016\/j.currproblcancer.2020.100617","article-title":"Altered expression of TGF-\u03b21 and TGF-\u03b2R2 in tissue samples compared to blood is associated with food habits and survival in esophageal squamous cell carcinoma","volume":"45","author":"Talukdar","year":"2021","journal-title":"Curr. Probl. Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fimmu.2018.00050","article-title":"Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage polarization at the site of inflammation","volume":"9","author":"Veremeyko","year":"2018","journal-title":"Front. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2021.06.008","article-title":"Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy","volume":"517","author":"Wang","year":"2021","journal-title":"Cancer Lett."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s13277-015-4016-8","article-title":"Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00520-019-04820-2","article-title":"Patient-reported outcomes of the relative severity of side effects from cancer radiotherapy","volume":"28","author":"Williams","year":"2020","journal-title":"Support. Care Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cellbi.2008.10.011","article-title":"Role of viral induced vascular endothelial growth factor (VEGF) production in pleural effusion and malignant mesothelioma","volume":"33","author":"W\u00f6rnle","year":"2009","journal-title":"Cell Biol. Int."},{"key":"B59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"B60","doi-asserted-by":"publisher","first-page":"15750","DOI":"10.1038\/s41598-020-72837-3","article-title":"HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment","volume":"10","author":"Wuerfel","year":"2020","journal-title":"Sci. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1038\/s41467-019-12680-x","article-title":"NFAT primes the human RORC locus for ROR\u03b3t expression in CD4(+) T cells","volume":"10","author":"Yahia-Cherbal","year":"2019","journal-title":"Nat. Commun."},{"key":"B62","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","article-title":"Gene body methylation can alter gene expression and is a therapeutic target in cancer","volume":"26","author":"Yang","year":"2014","journal-title":"Cancer Cell."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00432-021-03574-x","article-title":"Involvement of APRIL in Helicobacter pylori-related gastric cancer","volume":"147","author":"Zhang","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Sci. (New York, NY)"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.969476\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T06:43:03Z","timestamp":1663224183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.969476\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":65,"alternative-id":["10.3389\/fgene.2022.969476"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.969476","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"article-number":"969476"}}